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plished by using retroviral or lentiviral vectors. However, such viral vector-mediated transgene
expression is often at low levels and can be reduced over time due to low copy numbers and/or
chromatin remodeling repression. The piggyBac transposon has emerged as a promising non-
viral vector system for efficient gene transfer into mammalian cells. Despite its inherent ad-
vantages over lentiviral and retroviral systems, piggyBac system has not been widely used,
at least in part due to their limited manipulation flexibilities. Here, we seek to optimize pig-
gyBac-mediated transgene expression and generate a more efficient, user-friendly piggyBac
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A simplified piggyBac system for stable gene expression 97adenoviruses expressing piggyBac transposase (PBase), we demonstrate that adenovirus-
mediated PBase expression significantly enhances the integration efficiency and expression
level of transgenes in mesenchymal stem cells and osteosarcoma cells, compared to that ob-
tained from co-transfection of the CMV-PBase plasmid. We further determine the drug selec-
tion timeline to achieve optimal stable transgene expression. Moreover, we demonstrate that
the transgene copy number of piggyBac-mediated integration is approximately 10 times higher
than that mediated by retroviral vectors. Using the engineered tandem expression vector, we
show that three transgenes can be simultaneously expressed in a single vector with high effi-
ciency. Thus, these results strongly suggest that the optimized piggyBac system is a valuable
tool for making stable cell lines with sustained, high transgene expression.
Copyright ª 2014, Chongqing Medical University. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Introduction
Sustained and high level transgene expression may be
desired for studying themolecular and cellular functions of a
gene of interest, both in vitro and in vivo. However, it is well
known that stable transgene expression in stem cells or
progenitor cells is significantly reduced over time, if not
silenced.1,2 For example, in embryonic stem cells (ESCs),
control of the gene expression program that establishes and
maintains the ESC state is dependent on a small number of
master transcription factors, as most of the chromatin is in a
repressive state.3e7 Conventional stable transgene expres-
sion approaches usually employ a retroviral or lentiviral
vector to generate stable integration in stem cells. However,
transgene expression is often low or reduced over time.1,2
This phenomenon may be caused by either single or low
copy numbers of transgenes integrated into the host
genome, and/or epigenetic modifications of the constitutive
promoters (either viral promoters or non-viral housekeeping
gene promoters).3e5,8,9
The piggyBac transposon has emerged as one of the most
promising non-viral vector systems for efficient gene trans-
fer into mammalian cells.10e15 Transposons are mobile ge-
netic elements that can be used to integrate transgenes into
host cell genomes. The piggyBac transposon was originally
isolated from the cabbage looper moth, Trichoplusiani, and
has been recognized as one of the most efficient DNA
transposons for manipulating mammalian genomes.10,16e18
The piggyBac transposon system has two major compo-
nents, a donor plasmid (or transfer vector), carrying the
gene of interest flanked by two terminal repeat domains,
and a helper plasmid, expressing piggyBac transposase
(PBase) that catalyzes the movement of the transposon.
Although the piggyBac transposon has several distinct ad-
vantages over the lentiviral and/or retroviral systems, such
as large cargo size, multiple copy integration, and leaving no
footprint,10,11 the use of this system has been limited. One
factor that may hamper the widespread use of the piggBac
system is the limited availability of piggyBac transfer vectors
with high manipulation flexibilities.
In this study, we seek to optimize the piggyBac-mediated
efficient transgene expression and attempt to generate a
more efficient and user-friendly piggyBac system. To
accomplish this objective, we first engineer a panel ofversatile piggyBac vectors with different promoters, drug
selection markers, and tandem expression cassettes. We
further construct recombinant adenoviruses expressing the
PBase. Using mouse mesenchymal stem cells (iMEFs) and a
human osteosarcoma line (143B), we demonstrate that
adenovirus-mediated PBase expression significantly en-
hances the integration efficiency and expression level of
transgenes both in vitro and in vivo, compared with that
obtained from the co-transfection of a PBase expression
plasmid. We also determine the drug selection timeline
needed to achieve optimal stable transgene expression.
Furthermore, we demonstrate that the transgene copy
number of piggyBac-mediated integration is approximately
10 times higher than that mediated by retroviral vectors.
Using the engineered tandem expression vector system, we
show that three transgenes can be simultaneously expressed
in a single vector with high efficiency. Therefore, our results
demonstrate that the optimized piggyBac transposon system
should be a valuable tool for making stable cell lines with
sustained and high transgene expression.
Materials and methods
Cell culture and chemicals
HEK-293 and 143B cells were obtained from ATCC (Mana-
ssas, VA). iMEFs are mouse embryonic fibroblasts that have
been reversibly immortalized as previously described.19,20 A
recently engineered, highly efficient adenovirus packaging
and production line 293pTP was used for adenovirus gen-
eration and/or amplification.21 These cell lines were
maintained in complete Dulbecco’s Modified Eagle Medium
(DMEM).22e26 Unless indicated otherwise, all chemicals
were purchased from SigmaeAldrich (St. Louis, MO) or
Thermo Fisher Scientific (Pittsburgh, PA).
Construction of the versatile piggyBac transposon
system and establishment of stable cell lines
The parental piggyBac vector was purchased from System
Biosciences Inc. (Mountain View, CA). The essential com-
ponents of the piggyBac transfer vector, including the pig-
gyBac terminal repeats (PB-TRs) and core insulators (CIs),
98 X. Chen et al.were subcloned into a spectinomycin resistance-conferring
plasmid vector, which contains a large linker with multiple
restriction sites. The MPB vector was constructed by sub-
cloning the blasticidin S selection marker (BSD) cassette
and the constitutive human elongation factor a and HIV
enhancer hybrid promoter (hEFH)-driven gene expression
cassette. MPB2, 3, and 4 vectors were constructed by
cloning 1, 2 or 3 copies of hEFH-SV40Pa cassettes into the
MPB vector (Fig. 1A, panel a). The MPH vector was con-
structed by replacing the BSD selection marker with aFig. 1 Schematic representation of the modified piggyBac vect
Various piggyBac transfer vectors containing different promoters an
Blasticidin S marker (BSD) (a), hEFH promoter and Hygromycin B ma
CMV promoter and Geneticin/G418 marker (neo/G418) (d ). Repre
piggyBac; PB-TR, piggyBac terminal repeats. (B) the generation
(PBase). (a) The schematic representation of adenoviruses that ex
(AdR-PBase). (b) The adenoviral vectors are shown to transduce
PBase. Subconfluent iMEFs were infected with Ad-PBase, AdR-PBase
subjected to semi-quantitative PCR using primers specific for PBashygromycin cassette (Fig. 1A, panel b). PBC series vectors
were constructed by replacing the hEFH with the CMV
promoter in MPB vectors (Fig. 1A, panel c). Similarly, the
PNC series vectors were obtained by replacing the BSD se-
lection marker with geneticin/G418 marker in the PBC
vectors (Fig. 1A, panel d ). Representative vector maps are
shown in Supplemental Fig. 1. Detailed vector sequence
information is available upon request.
For making the MPB-FLuc and MPB-mRFP constructs, the
coding regions of firefly luciferase and mRFP were PCRors and the transposase (PBase) expressing adenoviruses. (A)
d/or antibiotic selection markers; including hEFH promoter and
rker (hygro) (b), CMV promoter and Blasticidin S marker (c), and
sentative vector maps are shown in Supplemental Fig. 1. PB,
of recombinant adenoviruses expressing piggyBac transposase
press PBase, which also co-express eGFP (Ad-PBase) or mRFP
iMEF cells effectively. (c) Adenovirus-mediated expression of
, or AdR/GFP. Total RNA was isolated at 48 h after infection and
e. The samples were normalized with GAPDH expression level.
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MPB-KMR vector, the coding regions of human oncogenic
KRAS-G12D, human MDM2, and dominant-negative mouse
Runx2 were PCR amplified and subcloned sequentially into
the linker sites of the MPB4 vector, resulting in MPB-KMR.
These vectors were used to generate stable cell lines by co-
transfection with Lipofectamine (Invitrogen, Carlsbad, CA)
or transfection/infection with PBase, followed by blastici-
din S selection for 5 days. The empty vector was used as a
negative control (i.e., iMEF-MPB). All PCR amplified frag-
ments were verified by DNA sequencing. Detailed informa-
tion regarding vector constructs is available upon request.
Recombinant adenoviruses expressing piggyBac
transposase (PBase) and red/green fluorescent
proteins (R/GFP)
Recombinant adenoviruses were generated using the
AdEasy technology.23,27e29 Briefly, the coding region of
piggyBac transposase was PCR amplified and subcloned into
the adenoviral shuttle vector pAdTrack-TOX (co-expressing
eGFP) or pAdTrace-TOX (co-expressing mRFP), and subse-
quently used to generate recombinant adenoviruses in HEK-
293 or 293pTP cells,21 resulting in adenoviruses Ad-PBase
and AdR-PBase. An analogous control adenovirus AdR/GFP
expressing both eGFP and monomeric RFP (mRFP) was used
as a control.30e37 All adenovirus infections were added with
4e8 mg/ml polybrene to increase infection efficiency as
recently reported.38 All PCR amplified fragments were
verified by DNA sequencing. Again, detailed information
regarding vector constructs is available upon request.
RNA isolation and semi-quantitative RT-PCR
(sqPCR) analysis
Total RNA was isolated using TRIZOL Reagent (Invitrogen)
and subjected to reverse transcription reaction with hex-
amer and M-MuLV Reverse Transcriptase (New England
Biolabs, Ipswich, MA). The cDNA products were diluted 10-
to 100-fold and used as PCR templates. Semi-quantitative
PCR (sqPCR) was carried out as described.22,26,31,35,39e45
Gene-specific PCR primers were designed by using the
Primer3 Plus program (http://www.bioinformatics.nl/cgi-
bin/primer3plus/primer3plus.cgi) to amplify the genes of
interest (approximately 150e250 bp). A touchdown PCR
program was carried out as follows: 94 C for 2 min for 1
cycle; 92 C for 20 s, 68 C for 30 s, and 72 C for 12 cycles
with a decrease in 1 C per cycle; and then at 92 C for 20 s,
57 C for 30 s, and 72 C for 20 s for 20e25 cycles,
depending on transcript abundancy. The PCR products were
confirmed by resolving PCR products on 1.5% agarose gels.
All samples were normalized to GAPDH expression levels.
Genomic DNA isolation and sqPCR analysis of
blasticidin gene copy numbers
Stable blasticidin-resistant iMEF lines were established by
using the piggyBac transposon system and a retroviral
vector system, respectively. For generating the retrovirus-
mediated stable line, the packaged retroviruses were
used to transduce iMEF cells with multiple rounds ofinfection as previously described.19,34,42,46e48 Confluent
cells in 25 cm2 cell culture flasks were collected and lysed
in an alkaline lysis buffer (0.2 M NaOH/1 mM EDTA) at 85 C
for 20 min, followed by phenol-chloroform extraction and
ethanol precipitation. The retrieved genomic DNA was
diluted and subjected to sqPCR analysis using primers
specific for the blasticidin S gene. The sqPCR cycling pro-
gram was similar to that described above for sqRT-PCR.
Primers specific to the mouse Hey1 gene promoter were
used to normalize the genomic DNA levels among the
samples as previously described.26,37,49Establishment of stable lines expressing firefly
luciferase and firefly luciferase activity assay
To generate stable iMEFs or 143B cells, MPB-FLuc vector
was co-transfected with the piggyBac transposase expres-
sion vector pCMV-PBase or transfected/infected with Ad-
PBase into iMEF cells as reported.20,34,50 Stable cells were
selected in the presence of Blasticidin S. For firefly lucif-
erase reporter assay, subconfluent stable cells were lysed
at 36 h after plating, and then collected to measure lucif-
erase activity using the Luciferase Assay Kit (Promega,
Madison, WI) as described.51e54 Each assay condition was
performed in triplicate.Cell viability/proliferation assay (Crystal violet
assay)
Subconfluent cells were co-transfected or transfected/
infected with MPB-mRFP and pCMV-PBase or Ad-PBase.
After blasticidin selection at the indicated time points,
the viable cells were subjected to Crystal violet staining as
previously reported.30,55Intramuscular injection of human osteosarcoma
cells stably expressing firefly luciferase in nude
mice and Xenogen bioluminescence imaging
All animal work was conducted according to the protocol
approved by the Institutional Animal Care and Use Com-
mittee (IACUC). Intramuscular injection of tumor cells was
done as described.22,30,33,37,55 Briefly, human osteosarcoma
143B cells stably expressing firefly luciferase were
collected and resuspended in PBS for intramuscular injec-
tion (106 cells/injection) into the quadriceps of athymic
nude (nu/nu) mice (5 per group, 4e6 week old, female,
Harlan Laboratories, Indianapolis, IN). At two weeks post
injection, animal were anesthetized with isoflurane
attached to a nosecone mask within Xenogen IVIS 200 im-
aging system. For bioluminescence imaging, animals were
injected (i.p.) with D-Luciferin sodium salt (Gold BioTech-
nology) at 100 mg/kg in 0.1 ml sterile saline. Pseudoimages
were obtained by superimposing the emitted light over the
gray-scale photographs of the animals. Quantitative anal-
ysis was done by using Xenogen’s Living Image software as
described.37,56,57
100 X. Chen et al.Statistical analysis
All quantitative experiments were performed in triplicate,
or repeated three times. Data were expressed as
mean  SD. Statistical significance was determined by one-
way analysis of variance and the student’s t test. A value of
p < 0.05 was considered statistically significant.
Results and discussion
Construction of a panel of user-friendly and
versatile piggyBac transposon vectors
One of the factors that may hamper the widespread use of
the piggBac system is the limited availability of piggyBac
transfer vectors with diverse cloning flexibilities. In this
study, we sought to optimize piggyBac-mediated efficient
transgene expression. A typical piggyBac transposon system
consists of two essential components, the piggyBac transfer
vector and a vector to express piggyBac transposase
(PBase). We attempted to make the current piggyBac sys-
tem more efficient and user-friendly by creating a panel of
versatile piggyBac vectors with different promoters, drug
selection markers, and tandem expression cassettes, and
by introducing piggyBac transposase using adenoviral vec-
tors with high transduction efficiency.
To achieve these goals, we first subcloned the essential
components of the piggyBac transfer vector, including the
piggyBac terminal repeats (PB-TRs) and core insulators (CIs),
into an intermediate spectinomycin resistance-conferring
plasmid vector, which contains a large linker with multiple
restriction sites. The MPB vector was constructed by sub-
cloning the blasticidin S selection maker (BSD) cassette and
the constitutive promoter hEFH-driven gene expression
cassette. MPB2, 3, and 4 vectors were constructed by cloning
1, 2 or 3 copies of hEFH-SV40Pa cassettes into the MPB vector
(Fig. 1A, panel a). MPH vector was constructed by replacing
BSD selection marker with hygromycin cassette (Fig. 1A,
panel b). PBC series vectors were constructed by replacing
the hEFH with the CMV promoter in MPB vectors (Fig. 1A,
panel c). Similarly, the PNC series vectors were obtained by
replacing the BSD selection marker with geneticin/G418
marker in the PBC vectors (Fig. 1A, panel d ). Our recent
studies demonstrate that while the CMV promoter drives the
strongest gene expression in HEK-293 cells and certain can-
cer cells, the composite hEFH promoter provides more sus-
tained high level of transgene expression in progenitor cells,
such as iMEFs.9 Taken together, these transfer vectors pro-
vide a large of range of selections, which should facilitate
the use of piggyBac transposon system for stable gene
expression (Supplemental Fig. 1).
The traditional piggyBac system requires the co-
transfection of the transfer vector and the PBase expres-
sion vector. However, co-transfection of two or more plas-
mids usually decreases gene transfer efficiency. Thus, we
opted to take advantage of adenovirus-mediated efficient
transgene expression58e60 and generate recombinant ade-
noviruses that express PBase, namely Ad-PBase and AdR-
PBase (Fig. 1B, panel a). The generated adenoviruses were
shown to transduce mouse mesenchymal stem cells, iMEFs,
with high efficiency (Fig. 1B, panel b). Semi-quantitative RT-PCR analysis indicates that both Ad-PBase and AdR-PBase
mediate a high level of expression of PBase in the infected
cells (Fig. 1B, panel c). Thus, the use of adenovirus-mediated
PBase expression should significantly facilitate the efficient
delivery of piggyBac transposase into target cells.
Adenovirus-mediated PBase expression
significantly increases the efficiency of stable gene
expression
We next compared the efficiency of piggyBac transposon-
mediated integration by co-transfection of pCMV-PBase
and by infection with Ad-PBase. As the expression of the
transposase and ensuing transposase-mediated integration
may require a certain amount of time, it is conceivable that
non-transposon-mediated or random integration may occur
if drug selection (i.e., BSD in this case) starts too early.
Thus, we started drug selection at different time points,
and found that co-transfection of pCMV-PBase yielded
significantly lower numbers of stable clones than that by
Ad-PBase-mediated transduction (Fig. 2A, a, c, e, vs. b, d,
f). The drug selection commenced at 2, 4 and 6 days after
transfection/infection seemed to yield slightly increased
numbers of stable clones than that at 1 day after trans-
fection (data not shown), although no apparent increase in
colony numbers when drug selection was started at 6 days
after transfection/infection (Fig. 2A). This suggested that
the PBase-mediated integration reaches a peak between 2
and 4 days after transfection. Similar results were obtained
when MPB-mRFP was tested in iMEF cells (Fig. 2B). Thus,
these results strongly suggest that adenovirus-mediated
delivery of PBase may significantly facilitate piggyBac
transposon-mediated transgene integrations.
piggyBac-mediated stable integration is
significantly more efficient than that mediated by a
retroviral vector
By generating stable lines expressing firefly luciferase in
iMEFs, we quantitatively analyzed the efficiency and level of
stable gene expression affected by the different approaches
of PBase delivery, as well as the timing of drug selection.
Using the same amount of piggyBac transfer vector for
transfection of the iMEFs, we found that adenovirus-
mediated expression of PBase constantly yielded signifi-
cantly higher levels of luciferase activity than that by co-
transfection with pCMV-PBase (p< 0.001) (Fig. 3A). Further-
more, adding selection drug at day 4 or 6 led to slightly higher
gene expression, compared with that at day 2, especially in
the Ad-PBase infection groups (p< 0.05). These results sug-
gest that, while adenovirus-mediated PBase expression is
superior to the co-transfection of CMV-PBase plasmid, a
slightly delayed drug selection may increase the efficiency of
transposon-mediated stable transgene integration.
We next compared the efficiency of transgene integra-
tion mediated by piggyBac transposon vs. retroviral vector.
To determine the relative integration efficiency, we iso-
lated the genomic DNA from blasticidin-resistant stable
iMEF cells lines generated by co-transfection, transfection/
infection, and retroviral infection. Semi-quantitative PCR
was conducted to determine the relative levels of the
Fig. 2 Adenovirus-mediated expression of PBase significantly increases the efficiency of stable gene expression. (A) Comparison
of stable clone formation between CMV-PBase co-transfection and Ad-PBase infection. Subconfluent iMEFs were plated in 12-well
plates, and either transfected with MPB vector and CMV-PBase (co-transfection) or infected with Ad-PBase (transfection/infec-
tion). Blasticidin selection was initiated at 2, 4, and 6 days after transfection. The colonies were stained with Crystal violet. (B).
Subconfluent iMEFs were plated in 12-well plates and transfected with MPB-RFP vector and CMV-PBase or infected with Ad-PBase.
Blasticidin selection was initiated at 2, 4, and 6 days after transfection. Representative results are shown.
A simplified piggyBac system for stable gene expression 101blasticidin drug marker in the analyzed genomic DNA sam-
ples. We found that Ad-PBase transduction led to the
highest level of blasticidin marker integration, followed by
the CMV-PBase co-transfection, while retroviral infection
yielded the lowest (Fig. 3B, panel a). Quantitative analysis
indicated that the relative integration copy number for Ad-
PBase mediated transposition is 2.8 times of that by CMV-
PBase co-transfection, and 10.4 times of that mediated
by retroviral infection (p< 0.001) (Fig. 3B, panel b). These
results provide further evidence supporting that piggyBac
transposon-mediated stable transgene expression is supe-
rior to that of retroviral vectors.Adenovirus-mediated expression of piggyBac
transposase significantly enhances transposon-
mediated stable transgene expression in vivo
The above in vitro assays indicate that the delivery effi-
ciency of PBase into target cells may determine the efficacy
and stable expression level of the transgene of interest. We
further tested if this phenomenon held true in vivo. We
established stable human osteosarcoma 143B cells by
transfecting with MPB-FLuc, along with CMV-PBase co-
transfection or Ad-PBase infection. The resultant stable
143B-FLuc lines were injected intramuscularly into the
quadriceps of athymic nude mice. When the injected mice
were subjected to whole body Xenogen bioluminescence
imaging, we found that the Ad-PBase mediated trans-
position yielded a significantly higher level of luciferase
activity than that mediated by CMV-PBase co-transfection
in vivo (Fig. 4A). Quantitative analysis showed that therelative luciferase activity in the Ad-PBase-mediated
transposition group is 15.9 times of that in the CMV-PBase
co-transfection group (p< 0.001) (Fig. 4B). It is note-
worthy that similar results were obtained from the experi-
ments in several other cell lines, including iMEFs and human
osteosarcoma line MG63 (data not shown). Taken togther,
these in vivo results further confirm that adenovirus-
mediated expression of transposase significantly enhances
the efficacy of stable transgene expression.Multiple transgenes can be efficiently and stably
expressed by using a single piggyBac transposon
vector
One of the major advantages of the piggyBac transposon
system over retroviral or lentiviral vectors is the piggyBac
transposon’s capability of accommodating large cargo
sizes. It is conceivable that multiple transgene expression
cassettes can be integrated into target cells using a single
transposon vector. Using our modified piggyBac vector
MPB4, we sequentially subcloned three genes, including
human KRAS-G12D, human MDM2, and a dominant-negative
mutant of mouse Runx2, into the linker sites of this vector,
resulting in MPB-KMR (Fig. 5A).
It is conceivable that the amount of piggyBac transfer
vector used in transfection may affect the integration copy
numbers and hence the transgene expression levels. To test
this possibility, we transfected varied amounts of MPB-KMR
vector into the iMEF cells, which were infected with the
same titer of Ad-PBase, and subsequently selected with
blasticidin S. The empty vectorwas used as a negative control
Fig. 3 piggyBac-mediated stable integration is significantly more efficient than that mediated by retroviral vector. (A) Quantitative
analysis of luciferaseactivitymediatedbypiggyBac vectors. Subconfluent iMEFswereplated in12-wellplates,andeither transfectedwith
MPB-FLuc vector and CMV-PBase or infected with Ad-PBase. Blasticidin selection was initiated at 2, 4, and 6 days after transfection. The
stable cells were replated in 24-well plates for 24 h and lysed for firefly luciferase assay using the firefly Luciferase Assay kit (Promega).
Each assay condition was done in triplicate. (B) Comparison of piggyBac and retroviral vector-mediated gene integration. Genomic DNA
was isolated from Blasticidin-resistant stable iMEF lines generated by co-transfection, transfection/infection, and retroviral infection
(multiple rounds). The isolated genomicDNAwas subjected to semi-quantitative touchdownPCRusing theblasticidin-specificprimers.All
samples were normalized with mouse Hey1 primers specific for genomic DNA (a). The gel band intensity was quantitatively determined
(b). “**”, p< 0.001 for the relative BSD genomic copy number in the Ad-PBase group vs. the CMV-PBase or RV group.
102 X. Chen et al.(i.e., iMEF-MPB). Total RNA was isolated from exponentially
growing iMEF-KMR or iMEF-MPB cells, and subjected to semi-
quantitative RT-PCR analysis using gene-specific primers. We
found that there was a trend of elevated transgene expres-
sion with the increasing amounts of MPB-KMR vector used,
peaking at 1.0 mg per well of the 6-well plates (Fig. 5B).
Furthermore, we found that all three transgenes were
expressed at a high level, compared with that in the control
cell line (Fig. 5B). Thus, our results strongly suggest that the
modified piggyBac vectors may provide a useful platform for
efficient multiple transgene expression, which has been
significantly enhanced by the adenovirus-mediated trans-
duction of the piggyBac transposase.
The piggyBac transposon system offers significant
advantages over the retroviral and lentiviral
systems in establishing a sustained high level of
transgene expression
We have plenty of experiences using retroviruses and
have previously used the retroviral vector-mediated expres-
sion of SV40 T antigen to immortalize several sources of pro-
genitor cells, including MEFs.19,42,44,46,47,52 However, the
immortalization efficiency was relatively low because of thelow retrovirus titers associated with the large cargo size for
packaging.
The piggyBac transposon system should have several
distinct advantages over the retroviral system.10,11 First, pig-
gyBac vector can deliver large cargo sizes, up to 100 kb of DNA
fragments, into mammalian cells.10 Second, unlike retroviral
infection, liposome-based transfection is more efficient than
retroviral vector-mediated infection in vitro and piggyBac
vectors can be delivered into cells with multiple copies so it is
easy to achieve high levels of transgene expression. Third,
piggyBac exhibits non-random AT-rich integration site selec-
tivity and has a higher preference for integrations in regions
surrounding transcriptional start sites.18 Lastly, it is conceiv-
able that piggyBac transposon can be removed from the host
genome by its transposase and thus leaves no footprint. The
excision-only/dominant forms of mutant piggyBac trans-
posase have recently been reported.61,62.Technical considerations for using the optimized
piggyBac transposon system
In this study, we demonstrate that adenovirus-mediated
expression of piggyBac transposase significantly enhances
the efficiency of the transposon-mediated transgene
Fig. 4 Adenovirus-mediated expression of transposase significantly enhances stable transgene expression in vivo. Human oste-
osarcoma 143B cells stably expressing firefly luciferase were established by either co-transfecting pCMV-PBase or infecting with Ad-
PBase. Approximately 10^e6 exponentially growing cells were injected intramuscularly into the quadriceps of athymic mice nude
mice (male, 4e6 week old, 5 mice/group). Whole body bioluminescence imaging was conducted by using Xenogen IVIS 200 Imaging
system at 2 weeks after injection (A). The acquired signal data were quantitatively determined by using Xenogen’s Living Image
software (B). Representative images are shown.
A simplified piggyBac system for stable gene expression 103integration, as well as the sustained high expression levels
of transgenes. In order to achieve optimal outcomes,
several technical considerations are strongly suggested.
First, the Ad-PBase viral vector should be titrated in theFig. 5 The optimized piggyBac transposon system effectively ex
regions of human oncogenic KRAS-G12D, human MDM2, and dominan
the linker sites of the MPB4 vector, resulting in MPB-KMR. (B) Stable
doses of MPB-KMR into iMEFs in 6-well culture plates and infecting
vector was used as a negative control (i.e., iMEF-MPB). Total RNA w
cells, and subjected to semi-quantitative RT-PCR analysis using getarget cells or the cells to be used for making stable lines.
The ideal titers (or MOI, multiplicity of infection) may vary
dramatically among cell lines; and the optimal infection
efficiency is that about 50%e70% of the cells are positive forpresses multiple transgenes in a single vector. (A) The coding
t-negative mouse Runx2 were PCR amplified and subcloned into
cell line iMEF-KMR was established by transfecting with varied
with Ad-PBase, followed by blasticidin S selection. The empty
as isolated from exponentially growing iMEF-KMR or iMEF-MPB
ne-specific primers. Representative results are shown.
104 X. Chen et al.GFP signal at 24 h post infection. Second, the amount of
piggyBac transfer vectors used for transfection should be
sufficiently high so maximal numbers of cells can be
transfected. As adenoviral infection should be more effi-
cient than transfection, it is generally assumed that most,
if not all, of the transfected cells are infected by Ad-PBase.
Lastly, the start points of drug selection may also affect the
quality of the stable lines. As it will take time for PBase to
express and carry out the transposition function, adding
selection antibiotics too early (e.g., within 24 h after
transfection/infection) may generate drug-resistant cells
that survive the selection by forced random integration,
rather than true transposition, of the piggyBac transfer
vectors. Our results indicate that drug selection should be
initiated between 2 and 4 days after transfection/infec-
tion. It’s noteworthy that the piggyBac vectors can be
further engineered in such to stably expression sgRNAs for
the CRISPR genome-editing system. Taken together, the
above findings demonstrate that the optimized piggyBac
transposon system is a valuable tool for making stable cell
lines with sustained and high transgene expression.
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